In the midst of June’s peak wedding season, Highridge Medical LLC called it splitsville – selling its bone healing division ...

Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from ...

Researchers from the University of Arizona have unveiled that coordinated Y chromosome loss in both cancer cells and immune cells may explain the worse prognosis in people with this alteration. The ...

Transpire Bio Inc. has signed an exclusive license agreement with Suzhou Intragrand Pharma Co. Ltd. for ITG-1052 (lenamilast) ...

Bioage Labs Inc. is advancing its apelin receptor (APJ) agonist programs for obesity and other indications, and has entered ...

The U.S. Federal Trade Commission said it sent letters to 37 contact lens prescribers reminding them a failure to ...

Pharmaceutical Co. Ltd.’s LYN/BTK dual inhibitor, DZD-8586, saw tumor shrinkage in 94.1% of patients with relapsed or ...

Epimab Biotherapeutics Inc. licensed out a development-ready KLK2/CD3 bispecific T-cell engager (TCE) for advanced prostate ...

Researchers have discovered that reduced expression of the free fatty acid receptor 4 (FFAR4) is a biomarker of podocyte ...

Paradromics Inc. became the latest company developing a brain-computer interface (BCI) system to implant its technology, ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British ...

An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is ...